Joseph Vittiglio is Chief Business & Legal Officer of Finch Therapeutics Group, Inc.. Currently has a direct ownership of 31,364 shares of FNCH, which is worth approximately $39,832. The most recent transaction as insider was on Oct 21, 2022, when has been sold 3,636 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $5,054. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.4K
0% 3M change
0% 12M change
Total Value Held $39,832

Joseph Vittiglio Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 21 2022
SELL
Open market or private sale
$5,054 $1.39 p/Share
3,636 Reduced 10.39%
31,364 Common Stock
Jun 13 2022
BUY
Grant, award, or other acquisition
-
35,000 Added 50.0%
35,000 Common Stock

Also insider at

BLUE
bluebird bio, Inc. Healthcare
AMAG
AMAG PHARMACEUTICALS, INC.
JV

Joseph Vittiglio

Chief Business & Legal Officer
Waltham, MA

Track Institutional and Insider Activities on FNCH

Follow Finch Therapeutics Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FNCH shares.

Notify only if

Insider Trading

Get notified when an Finch Therapeutics Group, Inc. insider buys or sells FNCH shares.

Notify only if

News

Receive news related to Finch Therapeutics Group, Inc.

Track Activities on FNCH